Showing results (121-130 of 188) with videos related to
Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based studyChad G Rusthoven, Julie A Carlson, Timothy V Waxweiler, et al.Radiation Oncology (London, England)|April 12, 2011
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local controlMichelle A Stinauer, Brian D Kavanagh, Tracey E Schefter, et al.Nature Medicine|October 1, 1996
Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trialA A Vandenbark, Y K Chou, R Whitham, et al.International Journal of Radiation Oncology, Biology, Physics|May 12, 2009
Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapyNeal E Dunlap, Jing Cai, Gregory B Biedermann, et al.International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiationKerry W Eley, Stanley H Benedict, Theodore D K Chung, et al.Radiology|June 1, 2000
Gynecologic brachytherapy: digital fluoroscopy for placement verification and treatment planningB D Kavanagh, R D Zwicker, E M Segreti, et al.International Journal of Radiation Oncology, Biology, Physics|June 1, 1997
A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervixB D Kavanagh, H L Gieschen, R K Schmidt-Ullrich, et al.Advances in Radiation Oncology|June 13, 2024
The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung CancerDavid Chun Cheong Tsui, Douglas E Holt, Tejas Patil, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiformeChanghu Chen, Denise Damek, Laurie E Gaspar, et al.Molecular Immunology|March 21, 2007
The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulationD Kavanagh, R Burgess, D Spitzer, et al.Pageof 19